Ueno S, Hara Y
Second Department of Internal Medicine, Osaka University Medical School, Japan.
J Neurol Neurosurg Psychiatry. 1992 May;55(5):409-10. doi: 10.1136/jnnp.55.5.409.
A 59 year old man with ischaemic heart disease, developed the clinical and electromyographic changes of the Lambert-Eaton myasthenic syndrome after taking calcium antagonist, diltiazem. The symptoms appeared periodically with a rise and fall in serum level of diltiazem. Extensive search was made for systemic neoplasms and autoimmune diseases without success. Serum antibody to voltage operated calcium channel was not detected.
一名59岁患有缺血性心脏病的男性,在服用钙拮抗剂地尔硫䓬后出现了兰伯特-伊顿肌无力综合征的临床和肌电图改变。症状随血清地尔硫䓬水平的升降而周期性出现。对全身性肿瘤和自身免疫性疾病进行了广泛排查,但未获结果。未检测到针对电压门控钙通道的血清抗体。